Trial watch: integrin antagonist shows promise in MS

Nat Rev Drug Discov. 2012 Mar 1;11(3):178. doi: 10.1038/nrd3676.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Clinical Trials, Phase II as Topic / methods
  • Clinical Trials, Phase II as Topic / trends*
  • Humans
  • Integrin alpha4beta1 / antagonists & inhibitors*
  • Integrin alpha4beta1 / immunology
  • Integrins / antagonists & inhibitors
  • Integrins / immunology
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology

Substances

  • Integrin alpha4beta1
  • Integrins